Honda, Makoto https://orcid.org/0000-0001-5087-6367
Kimura, Shinya
Sasaki, Kaori
Wada, Masataka
Ito, Wakako
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP21H02856)
Tokyo Metropolitan Insitute of Medical Science ((operating expenses))
Article History
Received: 10 May 2021
Accepted: 28 August 2021
First Online: 25 September 2021
Declarations
:
: Dr. Honda has received consultant fees from Takeda Pharmaceutical Company, Alfresa Pharma Corporation and Ono Pharmaceutical Company for work completely outside this research. None of the other authors have any potential conflicts of interest to disclose.
: This is a clinical study and has been approved by Ethical Committees of Institute of Neuropsychiatry (permission number 188-2) and of Tokyo Metropolitan Institute of Medical Science [permission number 18-2 (3)] Written informed consents were obtained from all participants.